<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00999271</url>
  </required_header>
  <id_info>
    <org_study_id>HD-2009-0025</org_study_id>
    <nct_id>NCT00999271</nct_id>
  </id_info>
  <brief_title>Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism</brief_title>
  <official_title>On the Role of Glucose-dependent Insulinotropic Polypeptide, GIP, in Postprandial Metabolism in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this proposal is to examine whether endogenous GIP and exogenous GIP alone and in
      combination with insulin affect gastric emptying (GE), appetite, energy intake, energy
      expenditure (EE) and plasma levels of triglycerides (TAG), free fatty acids FFA) and glycerol
      in man.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment>30</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <description>30 healthy subjects without family history of diabetes or gastrointestinal disease, a normal oral glucose tolerance test (OGTT) and no intake of medicine</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Incretin hormone - Glucose-dependent insulinotropic polypeptide (GIP)</intervention_name>
    <description>two different dosages:
0.8 pmol/kg/min
1.5 pmol/kg/min for 300 minutes</description>
    <arm_group_label>Healthy subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed oral and written consent

          -  Caucasians over the age of 18 years

          -  Normal 75 g oral glucose tolerance test (OGTT)

          -  Normal blood haemoglobin concentration

          -  Normal plasma lipid profile

        Exclusion Criteria:

          -  First-degree relatives with diabetes and familial hypertriglyceridemia
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hvidovre Hospital</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2009</study_first_submitted>
  <study_first_submitted_qc>October 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2009</study_first_posted>
  <last_update_submitted>October 20, 2009</last_update_submitted>
  <last_update_submitted_qc>October 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>University of Copenhagen</name_title>
    <organization>University of Copenhagen</organization>
  </responsible_party>
  <keyword>Glucose-dependent insulinotropic polypeptide</keyword>
  <keyword>gastric emptying</keyword>
  <keyword>appetite</keyword>
  <keyword>energy intake</keyword>
  <keyword>lipid metabolism</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
    <mesh_term>Incretins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

